344 related articles for article (PubMed ID: 19532051)
21. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.
Powles T; Robinson D; Stebbing J; Shamash J; Nelson M; Gazzard B; Mandelia S; Møller H; Bower M
J Clin Oncol; 2009 Feb; 27(6):884-90. PubMed ID: 19114688
[TBL] [Abstract][Full Text] [Related]
22. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.
Khanna N; Elzi L; Mueller NJ; Garzoni C; Cavassini M; Fux CA; Vernazza P; Bernasconi E; Battegay M; Hirsch HH;
Clin Infect Dis; 2009 May; 48(10):1459-66. PubMed ID: 19348592
[TBL] [Abstract][Full Text] [Related]
23. Reaping the prevention benefits of highly active antiretroviral treatment: policy implications of HIV Prevention Trials Network 052.
Forsyth AD; Valdiserri RO
Curr Opin HIV AIDS; 2012 Mar; 7(2):111-6. PubMed ID: 22227586
[TBL] [Abstract][Full Text] [Related]
24. Modelling the impact of treatment with individual antiretrovirals.
Cambiano V; Phillips AN
Curr Opin HIV AIDS; 2011 Mar; 6(2):124-30. PubMed ID: 21505387
[TBL] [Abstract][Full Text] [Related]
25. The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study).
Vellozzi C; Brooks JT; Bush TJ; Conley LJ; Henry K; Carpenter CC; Overton ET; Hammer J; Wood K; Holmberg SD;
Am J Epidemiol; 2009 Mar; 169(5):642-52. PubMed ID: 19074775
[TBL] [Abstract][Full Text] [Related]
26. How does HIV impact on non-AIDS events in the era of HAART?
Barber TJ; Hughes A; Dinsmore WW; Phillips A
Int J STD AIDS; 2009 Jan; 20(1):1-3. PubMed ID: 19103883
[TBL] [Abstract][Full Text] [Related]
27. Predicting and monitoring antiretroviral adherence.
Gross R
LDI Issue Brief; 2007; 13(2):1-4. PubMed ID: 18354853
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.
Protopopescu C; Raffi F; Roux P; Reynes J; Dellamonica P; Spire B; Leport C; Carrieri MP;
J Antimicrob Chemother; 2009 Sep; 64(3):599-606. PubMed ID: 19602563
[TBL] [Abstract][Full Text] [Related]
29. Antiretroviral rounds. The when, why and how of switching.
Henry K; Daar ES
AIDS Clin Care; 2003 Jun; 15(6):58-9. PubMed ID: 12866482
[No Abstract] [Full Text] [Related]
30. Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119).
Molina JM; Levy Y; Fournier I; Hamonic S; Bentata M; Beck-Wirth G; Gougeon ML; Venet A; Madelaine I; Sereni D; Jeanblanc F; Boulet T; Simon F; Aboulker JP;
J Infect Dis; 2009 Jul; 200(2):206-15. PubMed ID: 19508157
[TBL] [Abstract][Full Text] [Related]
31. The case for earlier treatment of HIV infection.
Holmberg SD; Palella FJ; Lichtenstein KA; Havlir DV
Clin Infect Dis; 2004 Dec; 39(11):1699-704. PubMed ID: 15578373
[TBL] [Abstract][Full Text] [Related]
32. Withdrawal symptoms as a predictor of mortality in patients HIV-infected through drug use and receiving highly active antiretroviral therapy (HAART).
Michel L; Giorgi R; Villes V; Poizot-Martin I; Dellamonica P; Spire B; Protopopescu C; Carrieri MP
Drug Alcohol Depend; 2009 Jan; 99(1-3):96-104. PubMed ID: 18774237
[TBL] [Abstract][Full Text] [Related]
33. Brazilian HIV-infected population: assessment of the needs of endodontic treatment in the post-highly active antiretroviral therapy era.
de Brito LC; da Rosa MA; Lopes VS; e Ferreira EF; Vieira LQ; Sobrinho AP
J Endod; 2009 Sep; 35(9):1178-81. PubMed ID: 19720212
[TBL] [Abstract][Full Text] [Related]
34. Directly observed therapy (DOT) for individuals with HIV: successes and challenges.
Mitty JA; Macalino G; Taylor L; Harwell JI; Flanigan TP
MedGenMed; 2003 Feb; 5(1):30. PubMed ID: 12827091
[TBL] [Abstract][Full Text] [Related]
35. Non-AIDS-defining cancers: should antiretroviral therapy be initiated earlier?
Cinti SK; Gandhi T; Riddell J
AIDS Read; 2008 Jan; 18(1):18-20, 26-32. PubMed ID: 18240449
[TBL] [Abstract][Full Text] [Related]
36. Neurocognitive impairment and neuroCART.
Wright E
Curr Opin HIV AIDS; 2011 Jul; 6(4):303-8. PubMed ID: 21546833
[TBL] [Abstract][Full Text] [Related]
37. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
[TBL] [Abstract][Full Text] [Related]
38. Sustained immunological responses to highly active antiretroviral therapy at 36 months in a Ghanaian HIV cohort.
Collini P; Schwab U; Sarfo S; Obeng-Baah J; Norman B; Chadwick D; Bibby D; Bedu-Addo G
Clin Infect Dis; 2009 Apr; 48(7):988-91. PubMed ID: 19231976
[TBL] [Abstract][Full Text] [Related]
39. Primary HIV-1 infection: to treat or not to treat?
Blankson JN
AIDS Read; 2005 May; 15(5):245-6, 249-51. PubMed ID: 15900634
[TBL] [Abstract][Full Text] [Related]
40. Early initiation of ART produces better clinical outcomes.
Clin Infect Dis; 2009 Apr; 48(8):iii. PubMed ID: 19301458
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
